Fig. 6From: Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancerThe pattern diagram of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancerBack to article page